Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart

Clinical trial NCT06822153 · COMPLETED

Trial details

NCT number: NCT06822153
Sponsor: Ahon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

QT Interval, Variation in

Start date: 2023-11-09
Primary completion: 2023-11-21
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.